Sven M van Dijk1, Hanne D Heerkens2, Dorine S J Tseng3, Martijn Intven2, I Quintus Molenaar4, Hjalmar C van Santvoort5. 1. Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands. 2. Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands. 3. Department of Radiotherapy, Erasmus Medical Center, Rotterdam, The Netherlands. 4. Department of Surgery, University Medical Center, Utrecht, The Netherlands. 5. Department of Surgery, University Medical Center, Utrecht, The Netherlands; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: h.c.vansantvoort@umcutrecht.nl.
Abstract
BACKGROUND: Patients undergoing pancreatoduodenectomy for pancreatic cancer have a high risk of major postoperative complications and a low survival rate. Insight in the impact of pancreatoduodenectomy on quality of life (QoL) is therefore of great importance. The aim of this systematic review was to assess QoL after pancreatoduodenectomy for pancreatic cancer. METHODS: A systematic review of the literature was performed according to the PRISMA guidelines. A systematic search of all the English literature available in PubMed and Medline was performed. All studies assessing QoL with validated questionnaires in pancreatic cancer patients undergoing pancreatoduodenectomy were included. RESULTS: After screening a total of 788 articles, the full texts of 36 articles were assessed, and 17 articles were included. QoL of physical and social functioning domains decreased in the first 3 months after surgery. Recovery of physical and social functioning towards baseline values took place after 3-6 months. Pain, fatigue and diarrhoea scores deteriorated postoperatively, but eventually resolved after 3-6 months. CONCLUSION: Pancreatoduodenectomy for malignant disease negatively influences QoL in the physical and social domains at short term. It will eventually recover to baseline values after 3-6 months. This information is valuable for counselling and expectation management of patients undergoing pancreatoduodenectomy.
BACKGROUND:Patients undergoing pancreatoduodenectomy for pancreatic cancer have a high risk of major postoperative complications and a low survival rate. Insight in the impact of pancreatoduodenectomy on quality of life (QoL) is therefore of great importance. The aim of this systematic review was to assess QoL after pancreatoduodenectomy for pancreatic cancer. METHODS: A systematic review of the literature was performed according to the PRISMA guidelines. A systematic search of all the English literature available in PubMed and Medline was performed. All studies assessing QoL with validated questionnaires in pancreatic cancerpatients undergoing pancreatoduodenectomy were included. RESULTS: After screening a total of 788 articles, the full texts of 36 articles were assessed, and 17 articles were included. QoL of physical and social functioning domains decreased in the first 3 months after surgery. Recovery of physical and social functioning towards baseline values took place after 3-6 months. Pain, fatigue and diarrhoea scores deteriorated postoperatively, but eventually resolved after 3-6 months. CONCLUSION: Pancreatoduodenectomy for malignant disease negatively influences QoL in the physical and social domains at short term. It will eventually recover to baseline values after 3-6 months. This information is valuable for counselling and expectation management of patients undergoing pancreatoduodenectomy.
Authors: Casey J Allen; Danny Yakoub; Francisco Igor Macedo; Austin R Dosch; Jessica Brosch; Vikas Dudeja; Ronda Ayala; Nipun B Merchant Journal: Ann Surg Date: 2018-10 Impact factor: 12.969
Authors: Jordan M Cloyd; Sarah Hyman; Tanya Huwig; Christina Monsour; Heena Santry; Celia Wills; Allan Tsung; John F P Bridges Journal: Support Care Cancer Date: 2020-10-08 Impact factor: 3.603
Authors: Adithya M Pathanki; Joseph A Attard; Elizabeth Bradley; Sarah Powell-Brett; Bobby V M Dasari; John R Isaac; Keith J Roberts; Nikolaos A Chatzizacharias Journal: World J Gastrointest Pathophysiol Date: 2020-04-12
Authors: Kelvin Allenson; Kea Turner; Brian D Gonzalez; Erin Gurd; Sarah Zhu; Nicole Misner; Alicia Chin; Melissa Adams; Laura Cooper; Diana Nguyen; Samer Naffouje; Diana L Castillo; Maria Kocab; Brian James; Jason Denbo; Jose M Pimiento; Mokenge Malafa; Benjamin D Powers; Jason B Fleming; Daniel A Anaya; Pamela J Hodul Journal: BMC Nutr Date: 2021-12-09
Authors: Teresa Macarulla; Andrew E Hendifar; Chung-Pin Li; Michele Reni; Hanno Riess; Margaret A Tempero; Amylou C Dueck; Marc F Botteman; Chinmay G Deshpande; Eleanor J Lucas; Do-Youn Oh Journal: Pancreas Date: 2020-03 Impact factor: 3.243
Authors: Patrick Téoule; Katharina Tombers; Mohammad Rahbari; Flavius Sandra-Petrescu; Michael Keese; Nuh N Rahbari; Christoph Reißfelder; Felix Rückert Journal: Chirurg Date: 2021-06-08 Impact factor: 0.955